Evaluation of the efficacy and safety of inhaled magnesium sulphate in combination with standard treatment in patients with moderate or severe COVID-19: A structured summary of a study protocol for a randomised controlled trial

被引：8

作者：

Pourdowlat, Guitti ^{[1
]}

Mousavinasab, Seyed Ruhollah ^{[2
]}

Farzanegan, Behrooz ^{[3
]}

Kashefizadeh, Alireza ^{[4
]}

Meybodi, Zohreh Akhoundi ^{[5
]}

Jafarzadeh, Maedeh ^{[1
]}

Baniasadi, Shadi ^{[6
]}

机构：

[1] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Chron Resp Dis Res Ctr, Tehran, Iran

[2] Shiraz Univ Med Sci, Dept Clin Pharm, Fac Pharm, Shiraz, Iran

[3] SBMU, Crit Care Qual Improvement Res Ctr, Tehran, Iran

[4] Shahid Beheshti Univ Med Sci, Shahid Dr Labbafinejad Hosp, Tehran, Iran

[5] Shahid Sadoughi Univ Med Sci, Yazd, Iran

[6] Shahid Beheshti Univ Med Sci, Natl Res Inst TB & Lung Dis NRITLD, Tracheal Dis Res Ctr, Tehran, Iran

来源：

关键词：

COVID-19; hypoxia; inhalation; magnesium sulphate; protocol; randomised controlled trial; respiratory tract symptoms;

D O I：

10.1186/s13063-021-05032-y

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

引用

页数：3